Skip to search boxSkip to navigationSkip to main content

Intermittent theta-burst stimulation alleviates hypoxia-ischemia-caused myelin damage and neurologic disability

  • Yu Feng
    ,
  • Zhihai Huang
    ,
  • Xiaohui Ma
    ,
  • Xuemei Zong
    ,
  • Peisheng Xu
    ,
  • Hung Wen Lin
*Corresponding author for this work
  • LSU Health Sciences Center - Shreveport
    ,
  • University of South Carolina
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

Neonatal hypoxia-ischemia (HI) results in behavioral deficits, characterized by neuronal injury and retarded myelin formation. To date, limited treatment methods are available to prevent or alleviate neurologic sequelae of HI. Intermittent theta-burst stimulation (iTBS), a non-invasive therapeutic procedure, is considered a promising therapeutic tool for treating some neurocognitive disorders and neuropsychiatric diseases. Hence, this study aims to investigate whether iTBS can prevent the negative behavioral manifestations of HI and explore the mechanisms for associations. We exposed postnatal day 10 Sprague-Dawley male and female rats to 2 h of hypoxia (6% O2) following right common carotid artery ligation, resulting in oligodendrocyte (OL) dysfunction, including reduced proliferation and differentiation of oligodendrocyte precursor cells (OPCs), decreased OL survival, and compromised myelin in the corpus callosum (CC) and hippocampal dentate gyrus (DG). These alterations were concomitant with cognitive dysfunction and depression-like behaviors. Crucially, early iTBS treatment (15 G, 190 s, seven days, initiated one day post-HI) significantly alleviated HI-caused myelin damage and mitigated the neurologic sequelae both in male and female rats. However, the late iTBS treatment (initiated 18 days after HI insult) could not significantly impact these behavioral deficits. In summary, our findings support that early iTBS treatment may be a promising strategy to improve HI-induced neurologic disability. The underlying mechanisms of iTBS treatment are associated with promoting the differentiation of OPCs and alleviating myelin damage.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

114821

Journal (Volume, Issue Number)

Experimental Neurology (Volume 378)

Publication milestones

  • Published - 08/2024

Publication status

Published - 08/2024

ISSN

0014-4886

Publication IDs

  • Scopus: 85194413226
  • PubMed: 38782349

Publication metrics

Metrics

Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
8
Citation count
5
Mentions
2

Funding Details

Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number RF1AG058603 and NIH Research Project Grant Program under Grant Number 1 R01 AG081874-01 .
FundersFunding numbers
NIA
-
NIH
1 R01 AG081874-01, RF1AG058603